| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PNT | POINT Biopharma Global Inc. | BVF PARTNERS L P/IL | Former 10% Owner | Dec 18, 2023 | Sale | $12.45 | 17,161,278 | 213,657,908 | 0 | Dec 20, 2023, 06:09 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Nov 15, 2023 | Buy | $5.00 | 931,556 | 4,657,687 | 5,155,739 | Nov 17, 2023, 04:54 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Nov 16, 2023 | Buy | $5.38 | 295,745 | 1,592,202 | 5,309,432 | Nov 17, 2023, 04:54 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Nov 03, 2023 | Buy | $14.07 | 197,699 | 2,781,407 | 2,656,191 | Nov 06, 2023, 06:07 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Nov 02, 2023 | Buy | $11.64 | 216,406 | 2,519,918 | 2,552,306 | Nov 06, 2023, 06:07 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Nov 02, 2023 | Buy | $3.60 | 783,709 | 2,821,352 | 4,662,402 | Nov 03, 2023, 05:37 PM | |
| OLMA | Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director | Sep 12, 2023 | Buy | $9.84 | 1,505,932 | 14,818,371 | 4,688,954 | Sep 14, 2023, 04:25 PM | |
| CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Jun 26, 2023 | Option Exercise | $9.10 | 7,286,874 | 66,310,556 | 0 | Jun 28, 2023, 06:26 PM | |
| CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Jun 26, 2023 | Option Exercise | $9.10 | 1,569,286 | 14,280,503 | 0 | Jun 28, 2023, 06:26 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jan 11, 2023 | Buy | $29.89 | 22,110 | 660,799 | 2,491,703 | Jan 13, 2023, 05:08 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jan 12, 2023 | Buy | $31.24 | 18,897 | 590,391 | 2,494,688 | Jan 13, 2023, 05:08 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Jan 05, 2023 | Buy | $18.39 | 19,000 | 349,319 | 1,788,168 | Jan 09, 2023, 05:44 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Jan 06, 2023 | Buy | $21.98 | 3,249 | 71,419 | 1,789,844 | Jan 09, 2023, 05:44 PM | |
| THRD | Third Harmonic Bio, Inc. | BVF PARTNERS L P/IL | 10% Owner | Dec 20, 2022 | Buy | $4.11 | 214,063 | 879,499 | 2,332,638 | Dec 22, 2022, 06:49 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Nov 08, 2022 | Buy | $5.83 | 1,710,358 | 9,971,387 | 2,870,985 | Nov 10, 2022, 06:31 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 23, 2022 | Buy | $16.50 | 16,600 | 273,850 | 1,780,495 | Sep 27, 2022, 07:22 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 26, 2022 | Buy | $16.83 | 6,360 | 107,050 | 1,783,834 | Sep 27, 2022, 07:22 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 27, 2022 | Buy | $16.89 | 1,682 | 28,409 | 1,784,838 | Sep 27, 2022, 07:22 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 15, 2022 | Buy | $17.96 | 5,575 | 100,138 | 1,576,913 | Sep 16, 2022, 06:30 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 16, 2022 | Buy | $17.89 | 24,293 | 434,536 | 1,773,780 | Sep 16, 2022, 06:30 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 14, 2022 | Buy | $17.25 | 26,441 | 456,044 | 1,571,338 | Sep 16, 2022, 06:30 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Aug 22, 2022 | Buy | $26.00 | 545,525 | 14,183,650 | 2,480,742 | Aug 23, 2022, 05:35 PM | |
| CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Aug 09, 2022 | Sale | $6.12 | 7,210,566 | 44,128,663 | 235,130 | Aug 11, 2022, 05:52 PM | |
| CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Aug 09, 2022 | Sale | $6.12 | 1,289,434 | 7,891,336 | 6,148 | Aug 11, 2022, 05:52 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 13, 2022 | Buy | $12.73 | 149,161 | 1,898,819 | 4,443,423 | Jun 15, 2022, 06:15 PM | |
| OLMA | Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director | Jun 10, 2022 | Buy | $4.03 | 200,000 | 806,900 | 3,913,676 | Jun 14, 2022, 04:46 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 02, 2022 | Buy | $11.68 | 1,186,045 | 13,855,852 | 4,011,604 | Jun 06, 2022, 06:14 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 03, 2022 | Buy | $12.29 | 644,044 | 7,912,725 | 4,364,948 | Jun 06, 2022, 06:14 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 06, 2022 | Buy | $13.21 | 6,869 | 90,752 | 4,368,757 | Jun 06, 2022, 06:14 PM | |
| CGEM | Cullinan Oncology, Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 01, 2022 | Buy | $11.00 | 751,396 | 8,264,905 | 4,058,854 | Jun 03, 2022, 06:24 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | May 26, 2022 | Buy | $14.21 | 224,057 | 3,183,984 | 2,159,903 | May 31, 2022, 07:50 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | May 27, 2022 | Buy | $14.78 | 65,369 | 966,337 | 2,195,696 | May 31, 2022, 07:50 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | May 20, 2022 | Buy | $14.00 | 10,100 | 141,394 | 2,036,860 | May 24, 2022, 08:09 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | May 18, 2022 | Buy | $8.50 | 420,000 | 3,570,000 | 3,350,950 | May 20, 2022, 06:09 PM | |
| CGEM | Cullinan Oncology, Inc. | BVF PARTNERS L P/IL | 10% Owner | May 12, 2022 | Buy | $9.06 | 1,000,000 | 9,060,000 | 3,599,615 | May 16, 2022, 07:34 PM | |
| CGEM | Cullinan Oncology, Inc. | BVF PARTNERS L P/IL | 10% Owner | May 13, 2022 | Buy | $9.14 | 109,900 | 1,003,937 | 3,653,213 | May 16, 2022, 07:34 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | May 05, 2022 | Buy | $19.60 | 150,000 | 2,939,865 | 1,975,767 | May 09, 2022, 07:20 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | May 06, 2022 | Buy | $19.25 | 100,000 | 1,925,500 | 2,030,977 | May 09, 2022, 07:20 PM | |
| CGEM | Cullinan Oncology, Inc. | BVF PARTNERS L P/IL | 10% Owner | Apr 01, 2022 | Buy | $10.75 | 276,000 | 2,966,972 | 3,056,616 | Apr 05, 2022, 06:45 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jan 31, 2022 | Buy | $40.70 | 34,408 | 1,400,406 | 1,900,272 | Jan 31, 2022, 07:44 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jan 27, 2022 | Buy | $38.33 | 95,901 | 3,676,068 | 1,880,187 | Jan 31, 2022, 07:44 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jan 24, 2022 | Buy | $37.76 | 272,767 | 10,300,637 | 1,822,145 | Jan 26, 2022, 07:43 PM | |
| RPTX | Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Jan 19, 2022 | Buy | $14.10 | 997,961 | 14,071,250 | 3,126,562 | Jan 21, 2022, 05:12 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Jan 06, 2022 | Buy | $12.00 | 61,343 | 736,018 | 1,141,759 | Jan 10, 2022, 06:03 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Jan 07, 2022 | Buy | $12.00 | 496,385 | 5,956,620 | 1,734,960 | Jan 10, 2022, 06:03 PM | |
| OLMA | Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director | Nov 30, 2021 | Buy | $9.39 | 739,675 | 6,945,770 | 3,755,093 | Dec 02, 2021, 08:45 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Oct 07, 2021 | Sale | $27.53 | 985,447 | 27,130,439 | 2,165,675 | Oct 08, 2021, 09:24 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Oct 08, 2021 | Sale | $27.79 | 147,267 | 4,092,035 | 2,085,664 | Oct 08, 2021, 09:24 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Sep 21, 2021 | Buy | $13.94 | 11,033 | 153,829 | 1,479,460 | Sep 23, 2021, 08:05 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Sep 13, 2021 | Buy | $16.49 | 392,269 | 6,468,516 | 1,473,119 | Sep 15, 2021, 05:23 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Jul 02, 2021 | Sale | $20.75 | 2,186,022 | 45,359,957 | 2,696,674 | Jul 07, 2021, 04:49 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Jul 01, 2021 | Buy | $15.65 | 317,279 | 4,965,416 | 1,113,757 | Jul 06, 2021, 07:34 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Jul 06, 2021 | Buy | $15.25 | 269,723 | 4,113,276 | 1,259,873 | Jul 06, 2021, 07:34 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Jul 01, 2021 | Buy | $47.00 | 544,166 | 25,575,802 | 1,664,104 | Jul 06, 2021, 06:40 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | May 21, 2021 | Buy | $15.94 | 121,986 | 1,944,701 | 940,581 | May 25, 2021, 08:31 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | May 24, 2021 | Buy | $15.90 | 1,361 | 21,633 | 941,300 | May 25, 2021, 08:31 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | May 18, 2021 | Buy | $16.65 | 191,197 | 3,183,430 | 865,148 | May 20, 2021, 07:18 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | May 19, 2021 | Buy | $15.88 | 17,268 | 274,290 | 874,339 | May 20, 2021, 07:18 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Apr 23, 2021 | Option Exercise | $16.90 | 1,105,896 | 18,694,901 | 714,942 | Apr 27, 2021, 08:41 PM | |
| RAIN | Rain Therapeutics Inc. | BVF PARTNERS L P/IL | Director | Apr 26, 2021 | Option Exercise | $14.90 | 27,413 | 408,478 | 729,732 | Apr 27, 2021, 08:41 PM | |
| CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Apr 01, 2021 | Buy | $2.50 | 2,000,000 | 5,000,000 | 4,085,933 | Apr 05, 2021, 08:15 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Mar 30, 2021 | Buy | $19.75 | 300,000 | 5,925,000 | 3,803,152 | Apr 01, 2021, 05:18 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Mar 22, 2021 | Buy | $22.75 | 79,500 | 1,808,625 | 3,638,152 | Mar 24, 2021, 05:15 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Mar 16, 2021 | Buy | $23.00 | 250,000 | 5,749,900 | 3,566,396 | Mar 18, 2021, 06:07 PM | |
| INFI | INFINITY PHARMACEUTICALS, INC. | BVF PARTNERS L P/IL | 10% Owner | Feb 11, 2021 | Sale | $5.37 | 2,260,085 | 12,133,492 | 4,448,421 | Feb 16, 2021, 04:35 PM | |
| IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | See Explanation of Responses | Feb 02, 2021 | Sale | $18.00 | 46,409 | 835,362 | 1,642,186 | Feb 04, 2021, 05:15 PM | |
| INFI | INFINITY PHARMACEUTICALS, INC. | BVF PARTNERS L P/IL | 10% Owner | Jan 22, 2021 | Sale | $4.14 | 5,848,520 | 24,205,855 | 5,663,912 | Jan 26, 2021, 05:27 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Jan 21, 2021 | Buy | $24.75 | 844,680 | 20,905,830 | 3,513,335 | Jan 25, 2021, 06:51 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Dec 18, 2020 | Buy | $16.05 | 160,000 | 2,568,000 | 3,055,521 | Dec 22, 2020, 07:04 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Dec 11, 2020 | Buy | $25.00 | 200,000 | 5,000,000 | 200,000 | Dec 15, 2020, 07:09 PM | |
| CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | See Explanaton of Responses | Dec 09, 2020 | Sale | $18.00 | 430,954 | 7,757,172 | 3,811,271 | Dec 11, 2020, 06:48 PM | |
| OLMA | Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director | Nov 19, 2020 | Buy | $19.00 | 1,135,334 | 21,571,346 | 3,392,663 | Nov 20, 2020, 08:02 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | See Explanaton of Responses | Nov 11, 2020 | Sale | $20.19 | 7,393,340 | 149,247,143 | 670,695 | Nov 13, 2020, 05:29 PM | |
| GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Nov 04, 2020 | Buy | $2.60 | 1,266,737 | 3,293,516 | 4,980,812 | Nov 06, 2020, 06:33 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Nov 04, 2020 | Buy | $4.88 | 416,562 | 2,034,572 | 4,594,679 | Nov 06, 2020, 06:30 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Nov 06, 2020 | Buy | $4.98 | 30,000 | 149,520 | 4,611,909 | Nov 06, 2020, 06:30 PM | |
| GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Oct 30, 2020 | Buy | $2.75 | 932,612 | 2,564,683 | 4,306,320 | Nov 03, 2020, 04:44 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Oct 06, 2020 | Buy | $5.03 | 345,241 | 1,738,288 | 4,336,875 | Oct 08, 2020, 05:27 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Sep 22, 2020 | Buy | $3.80 | 32 | 122 | 541,116 | Sep 24, 2020, 07:49 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 21, 2020 | Buy | $18.39 | 22,328 | 410,502 | 2,023,276 | Sep 23, 2020, 07:26 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 22, 2020 | Buy | $18.45 | 11,951 | 220,445 | 2,030,236 | Sep 23, 2020, 07:26 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 23, 2020 | Buy | $18.20 | 17,089 | 311,016 | 2,040,124 | Sep 23, 2020, 07:26 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Sep 15, 2020 | Buy | $11.75 | 146,754 | 1,724,360 | 2,940,553 | Sep 17, 2020, 07:42 PM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Sep 10, 2020 | Buy | $11.10 | 189,651 | 2,104,785 | 2,862,802 | Sep 14, 2020, 08:14 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 04, 2020 | Buy | $18.77 | 7,737 | 145,228 | 2,011,017 | Sep 10, 2020, 08:10 AM | |
| MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Sep 03, 2020 | Buy | $11.17 | 201,906 | 2,255,290 | 2,762,341 | Sep 08, 2020, 07:08 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Aug 31, 2020 | Buy | $18.48 | 16,005 | 295,782 | 1,997,210 | Sep 01, 2020, 08:37 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Sep 01, 2020 | Buy | $18.87 | 17,572 | 331,515 | 2,007,110 | Sep 01, 2020, 08:37 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Aug 28, 2020 | Buy | $19.17 | 2,044 | 39,187 | 1,988,067 | Sep 01, 2020, 08:37 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Aug 21, 2020 | Buy | $19.32 | 10,805 | 208,770 | 1,976,998 | Aug 25, 2020, 08:10 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Aug 24, 2020 | Buy | $19.31 | 11,683 | 225,591 | 1,983,502 | Aug 25, 2020, 08:10 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Aug 25, 2020 | Buy | $19.75 | 5,687 | 112,290 | 1,986,945 | Aug 25, 2020, 08:10 PM | |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Aug 21, 2020 | Option Exercise | $20.00 | 978,693 | 19,573,860 | 1,359,109 | Aug 25, 2020, 06:48 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 18, 2020 | Buy | $19.27 | 895 | 17,246 | 1,962,532 | Aug 20, 2020, 06:56 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 19, 2020 | Buy | $19.70 | 3,496 | 68,877 | 1,966,028 | Aug 20, 2020, 06:56 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 20, 2020 | Buy | $19.12 | 1,772 | 33,881 | 1,967,800 | Aug 20, 2020, 06:56 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 13, 2020 | Buy | $17.80 | 1,050 | 18,693 | 1,939,715 | Aug 14, 2020, 06:38 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 14, 2020 | Buy | $18.69 | 21,922 | 409,810 | 1,961,637 | Aug 14, 2020, 06:38 PM | |
| XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Aug 12, 2020 | Buy | $17.34 | 4,050 | 70,233 | 1,938,665 | Aug 14, 2020, 06:38 PM | |
| IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Jun 30, 2020 | Buy | $13.32 | 2,531 | 33,704 | 1,667,420 | Jul 02, 2020, 06:51 PM |
Menu